ArticleJournal of pain research2026
Comparative Effectiveness of Low-Dose Intra-Articular Ozone Therapy for Pain and Functional Outcomes in Patients with Knee Osteoarthritis: A Retrospective Cohort Study.
Article in Journal of pain research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Knee osteoarthritis is one of the leading causes of chronic musculoskeletal pain and disability worldwide. Although intra-articular ozone therapy has demonstrated analgesic effects, the optimal concentration for maximizing pain relief while preserving functional improvement remains uncertain. Our aim is to determine whether different low-dose ozone protocols differ in their ability to reduce pain and improve functional performance in patients with knee osteoarthritis. Patients and Methods: This retrospective comparative study included 45 patients aged 40-80 years with Kellgren-Lawrence grade II-III knee osteoarthritis. Patients were retrospectively classified into three groups according to the ozone protocol documented in their medical records: 1 μg/mL, 5 μg/mL, and 10 μg/mL, with 15 patients in each group. All patients received intra-articular ozone injections once weekly for 3 consecutive weeks. Outcomes were assessed at baseline and at week 4 using the Visual Analogue Scale (VAS), the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), and the 2-minute walking test. Results: The study included 45 patients, 7 men and 38 women, with a mean age of 59.62 ± 8.08 years. VAS, WOMAC pain, WOMAC physical function, and WOMAC total scores improved significantly in all three groups after treatment. WOMAC stiffness scores improved numerically in all groups but reached statistical significance only in the 5 μg/mL group. No significant between-group differences were found for changes in pain, stiffness, physical function, or total scores. The increase in 2-minute walking test distance was significantly greater in the 1 μg/mL group than in the 10 μg/mL group. No adverse events were documented in any group. Conclusion: Intra-articular ozone therapy was associated with short-term improvements in pain and functional outcomes in patients with knee osteoarthritis, with generally comparable results across the ozone concentrations evaluated. Because of the retrospective design, causal conclusions cannot be drawn, and the difference favoring the lowest concentration in walking distance should be considered exploratory. Prospective studies with larger sample sizes and longer follow-up are needed to confirm these findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.